Treatment Principles and Paradigm of Diabetic Microvascular Complications Responding Specifically to Traditional Chinese Medicine
10.13422/j.cnki.syfjx.20252393
- VernacularTitle:基于中医临床优势病种（糖尿病微血管并发症）的科技攻关思路与范式探讨
- Author:
Anzhu WANG
1
;
Xing HANG
2
;
Lili ZHANG
2
;
Xiaorong ZHU
3
;
Dantao PENG
1
;
Ying FAN
4
;
Min ZHANG
5
;
Wenliang LYU
2
;
Guoliang ZHANG
2
;
Xiai WU
1
;
Jia MI
6
;
Jiaxing TIAN
2
;
Wei ZHANG
7
;
Han WANG
8
;
Yuan XU
1
;
.LI PINGPING
9
;
Zhenyu WANG
10
;
Ying ZHANG
8
;
Dongmei SUN
11
;
Yi HE
12
;
Mei MO
12
;
Xiaoxiao ZHANG
13
;
Linhua ZHAO
2
Author Information
1. Shandong Provincial Hospital Affiliated to Shandong First Medical University，Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging， Ministry of Education，Jinan 250021，China
2. Guang'anmen Hospital，China Academy of Chinese Medical Sciences，Beijing 100053，China
3. Beijing Tongren Hospital，Capital Medical University，Beijing 100730，China
4. Shanghai Sixth People's Hospital，Shanghai 200233，China
5. Beijing Chaoyang Hospital，Capital Medical University，Beijing 100020，China
6. Affiliated Hospital of Changchun University of Chinese Medicine，Changchun 130021，China
7. Xi'an Hospital of Traditional Chinese Medicine，Xi'an 710021，China
8. Beijing University of Chinese Medicine，Beijing 100029，China
9. Peking Union Medical College Hospital，Beijing 100730，China
10. Institutes of Science and Development，Chinese Academy of Sciences，Beijing 100190，China
11. Guangdong Yifang Pharmaceutical Co.，Ltd.，Foshan 528244，China
12. National Key Laboratory of Chinese Medicine Modernization，Tianjin 300410，China
13. China Association of Chinese Medicine，Beijing 100029，China
- Publication Type:Journal Article
- Keywords:
diabetic microvascular complications;
diseases responding specifically to traditional Chinese medicine;
integrative medicine;
expert guidance recommendations
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2026;32(5):272-279
- CountryChina
- Language:Chinese
-
Abstract:
To explore the advantages of traditional Chinese medicine （TCM） and integrative TCM-Western medicine approaches in the treatment of diabetic microvascular complications （DMC）， refine key pathophysiological insights and treatment principles， and promote academic innovation and strategic research planning in the prevention and treatment of DMC. The 38th session of the Expert Salon on Diseases Responding Specifically to Traditional Chinese Medicine， hosted by the China Association of Chinese Medicine， was held in Beijing， 2024. Experts in TCM， Western medicine， and interdisciplinary fields convened to conduct a systematic discussion on the pathogenesis， diagnostic and treatment challenges， and mechanism research related to DMC， ultimately forming a consensus on key directions. Four major research recommendations were proposed. The first is addressing clinical bottlenecks in the prevention and control of DMC by optimizing TCM-based evidence evaluation systems. The second is refining TCM core pathogenesis across DMC stages and establishing corresponding "disease-pattern-time" framework. The third is innovating mechanism research strategies to facilitate a shift from holistic regulation to targeted intervention in TCM. The fourth is advancing interdisciplinary collaboration to enhance the role of TCM in new drug development， research prioritization， and guideline formulation. TCM and integrative approaches offer distinct advantages in managing DMC. With a focus on the diseases responding specifically to TCM， strengthening evidence-based support and mechanism interpretation and promoting the integration of clinical care and research innovation will provide strong momentum for the modernization of TCM and the advancement of national health strategies.
